Serveur d'exploration SRAS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Increased Antibody Affinity Confers Broad In Vitro Protection against Escape Mutants of Severe Acute Respiratory Syndrome Coronavirus

Identifieur interne : 000C71 ( Pmc/Corpus ); précédent : 000C70; suivant : 000C72

Increased Antibody Affinity Confers Broad In Vitro Protection against Escape Mutants of Severe Acute Respiratory Syndrome Coronavirus

Auteurs : Mridula Rani ; Meagan Bolles ; Eric F. Donaldson ; Thomas Van Blarcom ; Ralph Baric ; Brent Iverson ; George Georgiou

Source :

RBID : PMC:3416138

Abstract

Even though the effect of antibody affinity on neutralization potency is well documented, surprisingly, its impact on neutralization breadth and escape has not been systematically determined. Here, random mutagenesis and DNA shuffling of the single-chain variable fragment of the neutralizing antibody 80R followed by bacterial display screening using anchored periplasmic expression (APEx) were used to generate a number of higher-affinity variants of the severe acute respiratory syndrome coronavirus (SARS-CoV)-neutralizing antibody 80R with equilibrium dissociation constants (KD) as low as 37 pM, a >270-fold improvement relative to that of the parental 80R single-chain variable fragment (scFv). As expected, antigen affinity was shown to correlate directly with neutralization potency toward the icUrbani strain of SARS-CoV. Additionally, the highest-affinity antibody fragment displayed 10-fold-increased broad neutralization in vitro and completely protected against several SARS-CoV strains containing substitutions associated with antibody escape. Importantly, higher affinity also led to the suppression of viral escape mutants in vitro. Escape from the highest-affinity variant required reduced selective pressure and multiple substitutions in the binding epitope. Collectively, these results support the hypothesis that engineered antibodies with picomolar dissociation constants for a neutralizing epitope can confer escape-resistant protection.


Url:
DOI: 10.1128/JVI.00233-12
PubMed: 22696652
PubMed Central: 3416138

Links to Exploration step

PMC:3416138

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Increased Antibody Affinity Confers Broad
<italic>In Vitro</italic>
Protection against Escape Mutants of Severe Acute Respiratory Syndrome Coronavirus</title>
<author>
<name sortKey="Rani, Mridula" sort="Rani, Mridula" uniqKey="Rani M" first="Mridula" last="Rani">Mridula Rani</name>
<affiliation>
<nlm:aff id="aff1">Institute of Cellular and Molecular Biology</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Bolles, Meagan" sort="Bolles, Meagan" uniqKey="Bolles M" first="Meagan" last="Bolles">Meagan Bolles</name>
<affiliation>
<nlm:aff id="aff6">Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Donaldson, Eric F" sort="Donaldson, Eric F" uniqKey="Donaldson E" first="Eric F." last="Donaldson">Eric F. Donaldson</name>
<affiliation>
<nlm:aff id="aff5">Department of Epidemiology, School of Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Van Blarcom, Thomas" sort="Van Blarcom, Thomas" uniqKey="Van Blarcom T" first="Thomas" last="Van Blarcom">Thomas Van Blarcom</name>
<affiliation>
<nlm:aff id="aff2">Department of Chemical Engineering</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Baric, Ralph" sort="Baric, Ralph" uniqKey="Baric R" first="Ralph" last="Baric">Ralph Baric</name>
<affiliation>
<nlm:aff id="aff5">Department of Epidemiology, School of Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Iverson, Brent" sort="Iverson, Brent" uniqKey="Iverson B" first="Brent" last="Iverson">Brent Iverson</name>
<affiliation>
<nlm:aff id="aff1">Institute of Cellular and Molecular Biology</nlm:aff>
</affiliation>
<affiliation>
<nlm:aff id="aff3">Department of Chemistry and Biochemistry</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Georgiou, George" sort="Georgiou, George" uniqKey="Georgiou G" first="George" last="Georgiou">George Georgiou</name>
<affiliation>
<nlm:aff id="aff1">Institute of Cellular and Molecular Biology</nlm:aff>
</affiliation>
<affiliation>
<nlm:aff id="aff2">Department of Chemical Engineering</nlm:aff>
</affiliation>
<affiliation>
<nlm:aff id="aff4">Department of Molecular Genetics and Microbiology, The University of Texas at Austin, Austin, Texas, USA</nlm:aff>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PMC</idno>
<idno type="pmid">22696652</idno>
<idno type="pmc">3416138</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3416138</idno>
<idno type="RBID">PMC:3416138</idno>
<idno type="doi">10.1128/JVI.00233-12</idno>
<date when="2012">2012</date>
<idno type="wicri:Area/Pmc/Corpus">000C71</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000C71</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a" type="main">Increased Antibody Affinity Confers Broad
<italic>In Vitro</italic>
Protection against Escape Mutants of Severe Acute Respiratory Syndrome Coronavirus</title>
<author>
<name sortKey="Rani, Mridula" sort="Rani, Mridula" uniqKey="Rani M" first="Mridula" last="Rani">Mridula Rani</name>
<affiliation>
<nlm:aff id="aff1">Institute of Cellular and Molecular Biology</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Bolles, Meagan" sort="Bolles, Meagan" uniqKey="Bolles M" first="Meagan" last="Bolles">Meagan Bolles</name>
<affiliation>
<nlm:aff id="aff6">Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Donaldson, Eric F" sort="Donaldson, Eric F" uniqKey="Donaldson E" first="Eric F." last="Donaldson">Eric F. Donaldson</name>
<affiliation>
<nlm:aff id="aff5">Department of Epidemiology, School of Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Van Blarcom, Thomas" sort="Van Blarcom, Thomas" uniqKey="Van Blarcom T" first="Thomas" last="Van Blarcom">Thomas Van Blarcom</name>
<affiliation>
<nlm:aff id="aff2">Department of Chemical Engineering</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Baric, Ralph" sort="Baric, Ralph" uniqKey="Baric R" first="Ralph" last="Baric">Ralph Baric</name>
<affiliation>
<nlm:aff id="aff5">Department of Epidemiology, School of Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Iverson, Brent" sort="Iverson, Brent" uniqKey="Iverson B" first="Brent" last="Iverson">Brent Iverson</name>
<affiliation>
<nlm:aff id="aff1">Institute of Cellular and Molecular Biology</nlm:aff>
</affiliation>
<affiliation>
<nlm:aff id="aff3">Department of Chemistry and Biochemistry</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Georgiou, George" sort="Georgiou, George" uniqKey="Georgiou G" first="George" last="Georgiou">George Georgiou</name>
<affiliation>
<nlm:aff id="aff1">Institute of Cellular and Molecular Biology</nlm:aff>
</affiliation>
<affiliation>
<nlm:aff id="aff2">Department of Chemical Engineering</nlm:aff>
</affiliation>
<affiliation>
<nlm:aff id="aff4">Department of Molecular Genetics and Microbiology, The University of Texas at Austin, Austin, Texas, USA</nlm:aff>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Journal of Virology</title>
<idno type="ISSN">0022-538X</idno>
<idno type="eISSN">1098-5514</idno>
<imprint>
<date when="2012">2012</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<p>Even though the effect of antibody affinity on neutralization potency is well documented, surprisingly, its impact on neutralization breadth and escape has not been systematically determined. Here, random mutagenesis and DNA shuffling of the single-chain variable fragment of the neutralizing antibody 80R followed by bacterial display screening using anchored periplasmic expression (APEx) were used to generate a number of higher-affinity variants of the severe acute respiratory syndrome coronavirus (SARS-CoV)-neutralizing antibody 80R with equilibrium dissociation constants (
<italic>K
<sub>D</sub>
</italic>
) as low as 37 pM, a >270-fold improvement relative to that of the parental 80R single-chain variable fragment (scFv). As expected, antigen affinity was shown to correlate directly with neutralization potency toward the icUrbani strain of SARS-CoV. Additionally, the highest-affinity antibody fragment displayed 10-fold-increased broad neutralization
<italic>in vitro</italic>
and completely protected against several SARS-CoV strains containing substitutions associated with antibody escape. Importantly, higher affinity also led to the suppression of viral escape mutants
<italic>in vitro</italic>
. Escape from the highest-affinity variant required reduced selective pressure and multiple substitutions in the binding epitope. Collectively, these results support the hypothesis that engineered antibodies with picomolar dissociation constants for a neutralizing epitope can confer escape-resistant protection.</p>
</div>
</front>
</TEI>
<pmc article-type="research-article">
<pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Virol</journal-id>
<journal-id journal-id-type="iso-abbrev">J. Virol</journal-id>
<journal-id journal-id-type="hwp">jvi</journal-id>
<journal-id journal-id-type="pmc">jvi</journal-id>
<journal-id journal-id-type="publisher-id">JVI</journal-id>
<journal-title-group>
<journal-title>Journal of Virology</journal-title>
</journal-title-group>
<issn pub-type="ppub">0022-538X</issn>
<issn pub-type="epub">1098-5514</issn>
<publisher>
<publisher-name>American Society for Microbiology</publisher-name>
<publisher-loc>1752 N St., N.W., Washington, DC</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">22696652</article-id>
<article-id pub-id-type="pmc">3416138</article-id>
<article-id pub-id-type="publisher-id">00233-12</article-id>
<article-id pub-id-type="doi">10.1128/JVI.00233-12</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Vaccines and Antiviral Agents</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Increased Antibody Affinity Confers Broad
<italic>In Vitro</italic>
Protection against Escape Mutants of Severe Acute Respiratory Syndrome Coronavirus</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Rani</surname>
<given-names>Mridula</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bolles</surname>
<given-names>Meagan</given-names>
</name>
<xref ref-type="aff" rid="aff6">
<sup>f</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Donaldson</surname>
<given-names>Eric F.</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>e</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Van Blarcom</surname>
<given-names>Thomas</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>b</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Baric</surname>
<given-names>Ralph</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>e</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Iverson</surname>
<given-names>Brent</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>c</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Georgiou</surname>
<given-names>George</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>b</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>d</sup>
</xref>
</contrib>
<aff id="aff1">
<label>a</label>
Institute of Cellular and Molecular Biology</aff>
<aff id="aff2">
<label>b</label>
Department of Chemical Engineering</aff>
<aff id="aff3">
<label>c</label>
Department of Chemistry and Biochemistry</aff>
<aff id="aff4">
<label>d</label>
Department of Molecular Genetics and Microbiology, The University of Texas at Austin, Austin, Texas, USA</aff>
<aff id="aff5">
<label>e</label>
Department of Epidemiology, School of Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA</aff>
<aff id="aff6">
<label>f</label>
Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA</aff>
</contrib-group>
<author-notes>
<corresp>Address correspondence to George Georgiou,
<email>gg@che.utexas.edu</email>
.</corresp>
</author-notes>
<pub-date pub-type="ppub">
<month>9</month>
<year>2012</year>
</pub-date>
<volume>86</volume>
<issue>17</issue>
<fpage>9113</fpage>
<lpage>9121</lpage>
<history>
<date date-type="received">
<day>1</day>
<month>2</month>
<year>2012</year>
</date>
<date date-type="accepted">
<day>6</day>
<month>6</month>
<year>2012</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2012, American Society for Microbiology. All Rights Reserved.</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder>American Society for Microbiology</copyright-holder>
</permissions>
<self-uri xlink:title="pdf" xlink:type="simple" xlink:href="zjv01712009113.pdf"></self-uri>
<abstract>
<p>Even though the effect of antibody affinity on neutralization potency is well documented, surprisingly, its impact on neutralization breadth and escape has not been systematically determined. Here, random mutagenesis and DNA shuffling of the single-chain variable fragment of the neutralizing antibody 80R followed by bacterial display screening using anchored periplasmic expression (APEx) were used to generate a number of higher-affinity variants of the severe acute respiratory syndrome coronavirus (SARS-CoV)-neutralizing antibody 80R with equilibrium dissociation constants (
<italic>K
<sub>D</sub>
</italic>
) as low as 37 pM, a >270-fold improvement relative to that of the parental 80R single-chain variable fragment (scFv). As expected, antigen affinity was shown to correlate directly with neutralization potency toward the icUrbani strain of SARS-CoV. Additionally, the highest-affinity antibody fragment displayed 10-fold-increased broad neutralization
<italic>in vitro</italic>
and completely protected against several SARS-CoV strains containing substitutions associated with antibody escape. Importantly, higher affinity also led to the suppression of viral escape mutants
<italic>in vitro</italic>
. Escape from the highest-affinity variant required reduced selective pressure and multiple substitutions in the binding epitope. Collectively, these results support the hypothesis that engineered antibodies with picomolar dissociation constants for a neutralizing epitope can confer escape-resistant protection.</p>
</abstract>
</article-meta>
</front>
</pmc>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Pmc/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000C71 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 000C71 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    Pmc
   |étape=   Corpus
   |type=    RBID
   |clé=     PMC:3416138
   |texte=   Increased Antibody Affinity Confers Broad In Vitro Protection against Escape Mutants of Severe Acute Respiratory Syndrome Coronavirus
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/RBID.i   -Sk "pubmed:22696652" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a SrasV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021